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We report herein the unprecedented finding that -O-glucosides and also -O-mannosides, when 
conjugated on nanodiamond particles (ND) are not only stable towards the hydrolytic action of the 
corresponding matching glycosidases, but are also endowed with the ability to inhibit them. Moreover, 
conjugation of the O-glycosides to ND (glyco-ND) sees them transformed into inhibitors of mismatching 
enzymes (for which they do not serve as substrates even when in their monovalent, free form). The 
effects of the glyco-NDs have been demonstrated on a panel of commercial glycosidases and the 
inhibition found to be competitive and reversible and not to be related to any denaturation of enzymes by 
the ND-conjugates. Values for Ki in the low micromolar have been measured for certain glyco-ND (for 
example, a Ki value of 5.5 ± 0.2 M was measured for the glyco-ND against the -glucosidase from 
baker’s yeast) and found to depend on both the identity of the enzyme and the glyco-ND. The latter Ki 
value compares well with that obtained for the natural glucosidase inhibitor, 1-deoxynojirimycin (Ki of 
25 M  against the -glucosidase from baker’s yeast under identical assay conditions). The monovalent 
control O-glycosides were hydrolysed efficiently by the appropriate glycosidase. Glyco-ND bearing 50% 
loading of O-glycoside as well ND conjugated with both O-glucosides and O-mannosides (mixed) have 
also been assayed and shown also to inhibit the panel of glycosidases with potencies and selectivities 
different from those recorded for the 100% loaded ND and also from one another. The impact on factors 
such as glycotope density and heteromultivalency on inhibition is reminiscent of that typically 
encountered in carbohydrate-lectin recognition events. The abilities of the glyco-ND to bind, cross-link 
and aggregate concanavalin A, a lectin known to recognize both -O-D-mannosides and -O-D-
glucosides were assessed by a range of methods including an enzyme-linked lectin assay (ELLA), a two-
site sandwich ELLA and a turbidimetry assay, respectively and indeed seen to reflect their expected per 
glycotope affinity enhancements as compared to monovalent controls: the high avidity of the lectin for 
each respective glycosylated ND particle was consistent with the manifestation of potent multivalent 
effects driving lectin recognition and binding. 
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1. Introduction 
A considerable amount of effort has been devoted to studying the 
principles governing the interactions of natural glycans and their 
synthetic mimetics with glycan-specific protein partners 
(lectins).1 This has demonstrated that the multivalent presentation 
of a particular glycotope on an appropriate scaffold (i.e. cell-
membrane, dendrimer, polymer, nanoparticle, etc.) can affect 
significantly its potency and selectivity of binding with a given 
target protein, relative to that of a monovalent counterpart.2-13 
Indeed, the promise that specific lectin-mediated processes (i.e., 
pathogen recognition, viral entry, tumor migration and metastasis 
events, etc.) might be effectively modulated with a properly 
tailored multivalent ligand continues to see innovative 
glycoedifices proposed in the hope of obtaining effective 
carbohydrate-based therapeutics.14 In contrast, much less effort 
has been consecrated to unravelling the principles underpinning 
interactions of natural or synthetic multivalent glycans with 
proteins other than lectins, for example with glycosyl hydrolases 
(glycosidases).8-11, 13, 15-17 Glycosidases constitute a large and 
important family of enzymes that are responsible for assuring the 
proper biosynthesis and/or biodegradation of glycoproteins, 
glycolipids and also proteoglycans - the very entities that serve as 
ligands for complimentary lectins in vivo. 
We herein examine the behaviour of glycosidases towards a 
series of glycan-conjugated nanodiamonds (glyco-ND). Diamond 
nanoparticles (also termed nanodiamonds) are among the most 
promising new carbon based materials for biomedical 
applications.18-25 Advantages of ND over other carbon-based 
materials such as fullerenes and carbon nanotubes include their 
complete inertness, optical transparency, lack of significant 
significant cytotoxicity in a variety of cell types,26-28 as well as 
their ease of functionalization through a variety of methods 
depending on ultimate application. Mannose-functionalized ND, 
for example, has been shown to inhibit yeast-agglutination as 
well as human bladder-cell adherence by E. coli and most 
notably to be able to disrupt biofilm formation.18, 19 Indeed, the 
usefulness of various ND adducts for the interrogation of glycan-
mediated processes has been substantiated recently in a number 
of reports.18, 19, 25, 29, 30 These properties have been determinant in 
their choice to explore the utility of the inhibition behavior of 
glyco-ND towards glycosidases.    
We report herein the unprecedented finding that monosaccharide 
substrates of selected glycosyl hydrolases behave as inhibitors of 
their complementary (matching) enzyme, simply upon being 
conjugated in a multivalent fashion to an ND edifice. Also 
striking is the finding that multivalent presentation of a given 
monosaccharide motif on an ND can see the “switching on” of 
the inhibition of non-complementary (mismatching) glycosidases 
in a surface density-dependent manner. 
2. Experimental section 
2.1.  Materials 
N,N’-dicyclohexylcarbodiimide (DCC), 4-dimethyl 
aminopyridine (DMAP), anhydrous acetonitrile, L-ascorbic acid, 
copper(II) sulphate pentahydrate (CuSO4•5H2O, ≥98%), 
propargyl alcohol, ethylenediaminetetraacetic acid (EDTA), 
phenol, sulfuric acid (H2SO4), sodium ascorbate (≥98%), L-
ascorbic acid, methanol (MeOH), dichloromethane (DCM), 
acetonitrile, ethanol, tert-butanol (tert-BuOH) and sodium 
methoxide were obtained from Sigma-Aldrich and used without 
any further purification.  
Methyl 4-azidobenzoate solution in tert-butyl methyl ether 
(≥95%) and 4-azidobenzoic acid was purchased from TCI 
Europe, Belgium.  
The glycosidases -glucosidase (from bovine liver, cytosolic), -
galactosidase (from Aspergillus niger), -galactosidase (from 
green coffee beans), -glucosidase (from almonds), 
amyloglucosidase (from Aspergillus niger), -glucosidase 
(maltase, from yeast), isomaltase (from yeast), naringinase 
(Penicillium decumbes), -mannosidase (from Helix pomatia) 
and -mannosidase (from jack bean) used in the inhibition 
studies, as well as the corresponding o- and p-nitrophenyl 
glycoside substrates, concanavalin A, horse-radish peroxidase-
labelled concanavalin A, yeast mannan and 2,2'-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) 
were purchased from Sigma Chemical Co. Milli-Q water (18 
MΩ) was used for all experiments. Hydroxylated diamond (ND-
OH) particles were obtained from the International Technology 
Centre, Raleigh, NC, USA. All reagents and solvents were used 
without further purification unless stated. 
2.2. Synthesis of mannoside (1) and glucoside (2) (monovalent 
substrates)  
2.2.1 Methyl-4-[4-((α-D-mannopyranosyloxy)methyl)-1H-
1,2,3-triazol-1-yl]-benzoate (1): Ligand (1) was synthesized 
according to the literature with some modifications.3 A mixture 
of propargyl-mannose (45 mg, 0.21 mmol, 1.0 eq), 0.5 M of 
methyl 4-azidobenzoate solution in tert-butyl methyl ether (619 
µL, 0.31 mmol, 1.5 eq), CuSO4•5H2O (13 mg, 0.05 mmol, 0.25 
eq) and sodium ascorbate (18 mg, 0.11 mmol, 0.5 eq) was 
dissolved in degassed tert-BuOH/H2O (1:1, 8 mL) under 
nitrogen. After stirring for 1 day at 50 °C, the solvents were 
removed in vacuum and the crude mixture was purified by silica 
gel chromatography (DCM/MeOH 9:1) to yield ligand (1) as a 
colorless solid (48 mg, yield 59%); [α]D +50.8 (c 0.4, MeOH). Rf 
0.28 (4:1 DCM-MeOH). 1H NMR (300 MHz, CD3OD): δ 8.68 (s, 
1H, H-9), 8.22 (d, J = 8.9 Hz , 2H, ArH), 8.02 (d, J = 8.91 Hz , 
2H, ArH), 4.92 (d, J = 1.4 Hz, 1H, H-1), 4.90 (d, J = 12.5 Hz, 
1H, H-7b), 4.76 (d, J = 12.5 Hz, 1H, H-7a), 3.94 (s, 3H, OCH3), 
3.89 – 3.76 (m, 5H, H-2, H-3, H-4, H-6a, H-6b), 3.61 – 3.59 (m, 
1H, H-5) ; 13C NMR (75 MHz, CD3OD): δ 167.4 (C=O), 146.7 
(C8), 141.6, 132.3 (s), 131.0 (Ar), 123.6 (C9), 121.2 (s) (Ar), 
101.1 (C1), 75.1 (C5), 72.5 (C3), 72.1 (C2), 68.7 (C4), 63.1 (C6), 
60.8 (C7), 52.9 (OCH3); HRMS (ESI+): calcd.for C17H21N3O8 
[M + Na]+ 418.1221; found 418.1221; HPLC (C4, 254 nm): tR = 
10.065 (93.9%) (Supporting information Figure S1). 
2.2.2 Methyl 4-[4-((α-D-glucopyranosyloxy)methyl)-1H-1,2,3-
triazol-1-yl]-benzoate (2): A mixture of propargyl-glucose  (35 
mg, 0.16 mmol), 0.5 M of methyl 4-azidobenzoate solution in 
tert-butyl methyl ether (482 µL, 0.24 mmol), CuSO4•5H2O (10 
mg, 0.04 mmol) and sodium ascorbate (14 mg, 0.09 mmol, 0.5 
eq) was dissolved in degassed tert-BuOH/H2O (1:1, 6 mL) under 
nitrogen. After stirring for 1 day at 50 °C, the solvents were 
removed in vacuo and the crude product was purified on silica 
gel chromatography (DCM/MeOH 9:1) to yield ligand (2) as a 
colorless solid (49 mg, yield 77%); [α]D = +56.1 (c 0.6, MeOH). 
Rf 0.44 (4:1 DCM-MeOH). 
1H NMR (300 MHz, CD3OD): δ 8.69 
(s, 1H, H-9), 8.22 (d, J = 8.9 Hz , 2H, ArH), 8.01 (d, J = 8.91 Hz, 
2H, ArH), 4.97 (d, J = 3.75 Hz, 1H, H-1), 4.93 (d, J = 12.7 Hz, 
1H, H-7b), 4.78 (d, J = 12.7 Hz, 1H, H-7a), 3.94 (s, 3H, OCH3), 
3.85–3.26 (m, 6H, H-2, H-3, H-4, H-6a, H-6b, H-5), 13C NMR 
(75 MHz, CD3OD): δ 
13C NMR (75 MHz, MeOD) δ 167.3 
(C=O), 146.9 (C8), 141.6, 132.3 (s), 131.6 (Ar), 123.5 (C9), 
121.2 (s) (Ar), 99.9 (C1), 75.1 (C5), 74.1 (C3), 73.5 (C2), 71.8 
(C4), 62.7 (C6), 61.6 (C7), 52.9 (OCH3); HRMS (ESI+): 
calcd.for C17H21N3O8 [M + Na]
+ 418.1221; found 418.1220; 
HPLC (C4, 254 nm): tR = 9.525 (98.8%)(Supporting information 
Figure S1). 
2.3. Modification of diamond nanoparticles 
2.3.1. Azide-terminated ND particles (ND-N3): The 
functionalization of the ND particles was carried out essentially 
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as described previously for Man-ND:18 4-Azidobenzoic acid 
(0.20 mmol), DCC (0.22 mmol) and DMAP (0.066 mmol) were 
dissolved in 5 mL anhydrous acetonitrile. A suspension of ND-
OH particles (10 mg) in anhydrous acetonitrile (5 mL) was added 
and the mixture stirred at room temperature for 24 h under 
nitrogen. The formed ND-N3 particles were isolated by 
centrifugation at 10.000 rpm, purified through four consecutive 
wash/centrifugation cycles at 10.000 rpm with acetonitrile and 
ethanol, and finally oven dried at 50 °C for 24 h.  
2.3.2. Fabrication of Man-, Glc- and Glc/Man-ND 
(Multivalent Particles): ND-N3 particles (10 mg) were 
dispersed in water (10 mL) and sonicated for 30 min. The “click” 
reaction was performed by addition of an alkynyl carbohydrate (2 
mM) followed by CuSO4·5H2O (200 µM) and L-ascorbic acid 
(300 µM) and subsequent stirring of the resulting suspension for 
24 h at room temperature. The crude sugar-conjugated 
nanoparticles were isolated by centrifugation at 10.000 rpm. In 
order to remove residual copper a first cleaning step protocol 
consisting of three washing/centrifugation cycles with EDTA (1 
mM solution in water) was implemented. A  second cleaning 
protocol involving three consecutive washing/centrifugation 
cycles at 10.000 rpm with a water-ethanol mixture was also 
carried out. The resulting particles were finally oven-dried at 50 
°C for 24 h prior to use. 
For the Glc-ND (50 %) and Man-ND (50 %), the appropriate 
sugar (1 mM) and propargyl alcohol (1 mM) were mixed prior to 
being subjected to the ‘click’ with ND-N3 (10 mg) and processed 
as described above. Similarly, for the Glc/Man-ND (“mixed”), 
propargyl glucose and  propargyl mannose (1 mM) were mixed 
with tND-N3 (10 mg)  prior to being subjected to “click” 
conditions and processes as described above.  
 
2.4 Determination of the carbohydrate loading: A calibration 
curve for carbohydrate concentrations in solution was 
established.18 For this, a phenolic aqueous solution (5 wt%, 60 
µL) and concentrated H2SO4 (900 µL) was added to an aqueous 
carbohydrate solution (60 µL), stirred for 10 min and then an 
absorption spectrum of the mixture was recorded (Perkin Elmer 
Lambda 950 dual beam) against a blank sample (without 
carbohydrate). The absorbance of the solution was measured at 
two wavelengths: λ1=495 and λ2=570 nm and the absorbance 
difference (A495 – A570) plotted against the concentration of the 
corresponding carbohydrate. The quantity of surface-linked 
carbohydrate on glyco-ND was determined with a 60 µL 
aliquotof the corresponding ND particles solution in water, which 
was treated with phenol/H2SO4 following the same protocol 
described above. Propargyl alcohol-terminated ND particles were 
subjected to the identical procedure and served as a blank 
sample. 
2.5. Instrumentation 
2.5.1. Fourier transform infrared (FTIR) spectroscopy: FTIR 
spectra were recorded using a Perkin-Elmer Spectrum One FT-IR 
spectrometer with a resolution of 4 cm-1. Dried ND powder (1 
mg) was mixed with KBr powder (100 mg) in an agate mortar. 
The mixture was pressed into a pellet under 10 tons load for 2-4 
min and the spectrum was recorded immediately. Sixteen 
accumulative scans were collected. The signal from a pure KBr 
pellet was subtracted as a background.  
2.5.2. Particle size measurements: ND suspensions (20 µg.mL-
1) in water were sonicated. The particle size of the ND 
suspensions was measured at 25°C using a Zetasizer Nano ZS 
(Malvern Instruments S.A., Worcestershire, U.K.) in 173° 
scattering geometry and the zeta potential was measured using 
the electrophoretic mode. 
2.5.3 NMR data: 1H NMR spectra were recorded with a Bruker 
Advance 300 MHz spectrometer using the deuterated solvent as 
the lock and TMS as an internal standard. Chemical shifts (δ) and 
coupling constants (J) are expressed in ppm and Hertz (Hz), 
respectively. 
2.5.4. Transmission electron microscopy (TEM): TEM 
measurements were performed on a FEI Tecnai G2-F20 
microscope.  
2.5.5. X-ray photoelectron spectroscopy (XPS): XPS 
measurements were performed in a Specs analysis chamber, 
equipped with a monochromatized Al K X-ray source (h = 
1486.74 eV) and a Phoibos 150 mm radius hemispherical 
electron energy analyzer. The analyzer (constant) pass energy 
was set to 100 eV for survey spectra and at 20 eV for high 
resolution scans, with an estimated total (source + analyzer + 
core hole width) resolution of 0.85 eV for the N 1s spectra. The 
pressure in the analysis chamber was in 10-8 Pa vacuum range, 
and an electron flood gun operating at 1 eV energy and 100 A 
electron current was used to ensure sample neutralization. 
Electrons are recorded at normal emission in "Large Area Mode" 
of the Phoibos analyzer. The XPS data presented are 
deconvoluted by using mixed Lorentz/Gauss profiles with the 
CasaXPS software. 
2.5.6. GC-FID analysis: GC-FID was carried out using an 
Agilent 7820A chromatograph with an EPC injector fitted with a 
cross-linked 5% phenyl-dimethylsiloxane column (HP-5; 30 m x 
320 μm x 0.25 μm). Operating conditions were: injection port 
temperature 310 ºC; splitting ratio 25:1; injection volume 1 μL of 
derivatized samples; column oven temperature programmed 
from180 to 310 ºC at 5 ºC min-1, with a 25 min hold at 310 ºC; 
carrier gas helium (constant flow at 1.2 mL min-1); detector port 
temperature 310 ºC. Total acquisition time was 45 min. The 
identity of D-mannose (elution time 4.8/5.1 min) and D-glucose 
(elution time 4.9/5.2) was confirmed by comparison with the GC 
chromatograms of authentic samples. Calibration curves for 
quantitative determination were built by using a range of 
concentrations, from which response factors relative to the I.S. 
(elution time 8.3/8.5 min) were determined.  
2.6. Bioassays 
2.6.1. Inhibition assay to determine the interactions of Man-
ND, Glc-ND, Man-ND (50 %), Glc-ND (50 %) and Glc/Man-
ND with glycosidases: Inhibitory potencies were determined by 
spectrophotometrically measuring the residual hydrolytic 
activities of the glycosidases against the respective o- (for -
glucosidase/-galactosidase from bovine liver) or p-nitrophenyl 
- or -D-glycopyranoside, in the presence of the corresponding 
iminosugar derivative. Each assay was performed in phosphate or 
phosphate-citrate (for - or -mannosidase or amyloglucosidase) 
buffer at the optimal pH for each enzyme. The Km values for the 
different glycosidases used in the tests and the corresponding 
working pH are listed herein: -glucosidase (bovine liver), Km = 
2.0 mM (pH 7.3); -glucosidase (yeast), Km = 0.35 mM (pH 6.8); 
-glucosidase (almonds), Km = 3.5 mM (pH 7.3); -galactosidase 
(coffee beans), Km = 2.0 mM (pH 6.8); amyloglucosidase 
(Aspergillus niger), Km = 3.0 mM (pH 5.5); naringinase 
(Penicillium decumbes), Km = 2.7 mM (pH 6.8); -mannosidase 
(Helix pomatia), Km = 0.6 mM (pH 5.5); -mannosidase (jack 
bean), Km = 2.0 mM (pH 5.5). The reactions were initiated by 
addition of enzyme to a solution of the substrate in the absence or 
presence of various concentrations of inhibitor. After the mixture 
was incubated for 10-30 min at 37 ºC the reaction was quenched 
by addition of 1 M Na2CO3. The absorbance of the resulting 
mixture was determined at 405 nm or 505 nm. The Ki value and 
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enzyme inhibition mode were determined from the slope of 
Lineweaver-Burk plots and double reciprocal analysis using a 
Microsoft Office Excel 2003 program. 
 
2.6.2. Procedures to monitor the stability of glyco-ND and the 
monovalent reference ligand (1) and (2) towards -
mannosidase and -glucosidase: The susceptibility of glyco-
ND and the monovalent -D-mannopyranyl and -D-
glucopyranyl glycosides (1) and (2) towards -mannosidase and 
-glucosidase hydrolysis was examined by incubating each 
conjugate with the corresponding enzyme at 37 ºC under 
identical conditions to those above described for determination of 
the inhibition constants during 1 h and monitoring the formation 
of free mannose or glucose by gas chromatography (GC). For GC 
analysis, the samples were subjected to an oximation-
trimethylsilylation protocol as reported in Ref.31 Briefly, 
immediately after quenching, the samples were freeze-dried. To 
15-20 mg of each sample, deionized water (1 mL) was added. To 
100 μL of the resulting solution was then added 100 μL of 
internal standard (I.S.; 4 mg mL-1 phenyl β-D-glucopyranoside in 
acetone-water 1:9, v/v) and the final solution was evaporated to 
dryness at 60 ºC (drying oven). The residue was treated with 1 
mL of a solution of hydroxylamine in pyridine (20 mg mL-1) at 
60 ºC over 50 min. with mixing at intervals. 
Hexamethyldisilazane (200 μL) and trimethylchlorosilane (100 
μL) were then added, and the reaction mixtures were kept at 60 
ºC over a further 40 min period. Formation of a white precipitate 
was observed during this operation, which was separated by 
centrifugation (13.000 rpm, 5 min) before injection in the GC 
apparatus. It is worth noting that following oximation-
trimethylsilylation derivatization, reducing monosaccharides, 
provides two peaks in the GC chromatograms, corresponding to 
the syn- and anti-TMS-oximes, whereas the I.S. provides a single 
peak. 
 
2.6.3. Enzyme-Linked Lectin Assay (ELLA): Nunc-Inmuno™ 
plates (MaxiSorp™) were coated overnight with yeast 
(Saccaromices cerevisae) mannan at 100 L/well diluted from a 
stock solution of 10 g·mL-1 in 0.01 M phosphate buffer saline 
(PBS, pH 7.3 containing 0.1 mM Ca2+ and 0.1 mM Mn2+) at room 
temperature. The wells were then washed three times with 300 
L of washing buffer (containing 0.05% (v/v) Tween 20) 
(PBST). The washing procedure was repeated after each of the 
incubations throughout the assay. The wells were then blocked 
with 150 L/well of 1% BSA/PBS for 1 h at 37 ºC. After 
washing, the wells were filled with 100 L of serial dilutions of 
horseradish peroxidase labelled concanavalin A lectin (ConA-
HRP) from 10-1 to 10-5 mg mL-1 in PBS, and incubated at 37 ºC 
for 1 h. The plates were washed and 50 L/well of 2,2'-azinobis-
(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt 
(ABTS) (0.25 mg·mL-1) in citrate buffer (0.2 M, pH 4.0 with 
0.015% H2O2) was added. The reaction was stopped after 20 min 
by adding 50 L/well of 1 M H2SO4 and the absorbances were 
measured at 405 nm. Blank wells contained citrate-phosphate 
buffer. The concentration of lectin-enzyme conjugate that 
displayed an absorbance between 0.8 and 1.0 was used for 
inhibition experiments. 
In order to carry out the inhibition experiments, each glyco-ND 
or the control non-glycosylated ND sample was added in a serial 
of 2-fold dilutions (60 L/well) in PBS with 60 L of the desired 
ConA-peroxidase conjugate concentration on Nunclon™ (Delta) 
microtiter plates and incubated for 1 h at 37 ºC. The maximum 
concentration was kept in all cases at 150 M to prevent 
aggregation phenomena; below this concentration, no 
precipitation was observed under the experimental setup. The 
above solutions (100 L) were then transferred to the mannan-
coated microplates, which were incubated for 1 h at 37 ºC. The 
plates were washed and the ABTS substrate was added (50 
L/well). Color development was stopped after 20 min and the 
absorbances were measured. IC50 values, assumed to be 
proportional to the corresponding binding affinities, were 
calculated from the percentages of inhibition with up to eleven 
different concentrations of each conjugate sample as follows: 
% Inhibition = (A(no inhibitor)- A(with inhibitor))/A(no inhibitor) x 100  
Results in triplicate were used for the plotting the inhibition 
curves for each individual ELLA experiment. Typically, the IC50 
values (concentration required for 50% inhibition of the Con A-
yeast mannan association) obtained from several independently 
performed tests were in the range of ±12%. Nevertheless, the 
relative inhibition values calculated from independent series of 
data were highly reproducible. 
2.6.4. Two-site ELLA (sandwich assay): Nunc-Inmuno™ plates 
(MaxiSorp™) microtitration plates were coated with yeast 
mannan and blocked with BSA as described above. Unlabelled 
(therefore crosslinkable) ConA lectin was then added at 100 
L/well from a stock solution of 5 g/mL in 0.01 M phosphate 
buffer (PBS, pH 7.3, containing 0.1 mM Ca2+ and 0.1 mM Mn2+) 
for 2 h at 37 °C. The synthesized glyco-ND and the 
hydroxylated-ND negative control were used as stock solutions 
of 0.15 mmol/mL in PBS. The ligands were added in serial 2- to 
10-fold dilutions (50 L/well) in PBS and incubated at 37 °C. 
After 1 h, horseradish peroxidase-labeled ConA lectin (50 
L/well of 200-fold dilution of a 1 mg/mL stock solution in PBS, 
pH 7.3, containing 0.1 mM Ca2+ and 0.1 mM Mn2+) was added to 
the microtiter plates which were incubated for another hour at 37 
°C. The plates were washed with PBS, and 50 L/well of ABTS 
(1 mg/4 mL) in citrate-phosphate buffer (0.2 M, pH 4.0 with 
0.015% H2O2) was added. The reactions were stopped after 30 
min by adding 50 mL/well of 1 M H2SO4, and the optical density 
was measured at 405 nm relative to 570 nm (SI Figure S4). 
2.6.5. Turbidity Assay: Solutions of the glyco-ND (50 L) at 
the appropriate concentration (37.5, 18.7 and 9.3 M) in PBS 
were added to a solution of ConA (50 L; 1 mg mL-1 in PBS, pH 
7.3, containing 0.1 mm Ca2+ and 0.1 mm Mn2+). The time-
dependent turbidity kinetics was recorded by measuring the 
absorption coefficient at 490 nm at intervals of 1 min for 35 min. 
After 15 min, D-mannose was added to the suspensions to have 
an excess of about 2500-, 5000- and 10.000-fold relative to the 
ND sugar content to check the reversibility of the aggregation 
(SI, Figure S5, A-C). The initial rate of precipitation (Vi) was 
determined by linear fits of the initial portion of the data (SI, 
Figure S5, D).  
2.6.6. Two-Site Competitive Lectin―Glycosidase Enzyme-
Linked Lectin Assay: Nunc-Inmuno™ plates (MaxiSorp™) 
microtitration plates were coated with yeast mannan, blocked 
with BSA as described above and further coated with unlabelled 
ConA lectin at 100 L/well of a stock solution of 5 g/mL in 
0.01 M phosphate buffer (PBS, pH 7.3, containing 0.1 mM Ca2+ 
and 0.1 mM Mn2+) for 2 h at 37 °C. The glyco-ND, used as 75 
M solutions in PBS, were then added (50 L/well) and 
incubated at 37 °C. At this concentration, a classical two-site 
ELLA (see above) provided optical density values in the range 
0.61 to 0.45 (A.U.), which were normalized at 100% cross-
linking for the lectin-glycosidase competition experiments. The, 
yeast maltase in serial 2-fold dilutions (50 L/well) from a stock 
solution of 40 U/mL in PBS and ConA-HRP lectin (50 L/well 
of 100-fold dilution of a 1 mg/mL stock solution in PBS) were 
added and the microplates were incubated at 37 °C. The plates 
were washed with PBS and 50 L/well of 2,2'-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS, 1 
mg/4 mL) in citrate-phosphate buffer (0.2 M, pH 4.0 with 
0.015% H2O2) was added. The reactions were stopped after 30 
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min by adding 50 L/well of 1 M H2SO4. The optical density was 
then measured at 410 nm relative to 570 nm and plot against 
maltase concentration (SI Figure S6). Control experiments were 
conducted to confirm that the enzyme itself did not interact with 
ConA and that it retained its catalytic activity under the 
conditions of the assay. 
3. Results and Discussion 
The behavior of -mannosidase from jack bean and -
glucosidase from yeast, towards the corresponding O-mannosides 
and O-glucosides, respectively, when free in solution or upon 
being grafted on ND, was selected as the primary focus of the 
present investigation. The latter enzymes are commercially 
available and are routinely used for ascertaining the potency and 
selectivity patterns of putative glycosidase inhibitors. Moreover, 
simple -mannosides and -glucosides are accepted as substrates 
by their respective -mannosidase and -glucosidase (matching 
enzymes). For the sake of completeness, a -mannosidase, a -
glucosidase and also - and -galactosidases, none of which act 
on either -mannosides or -glucosides, were included in the 
evaluation panel (mismatching enzymes). -O-Mannoside- and 
-O-glucoside-grafted-ND (Man- and Glc-ND, respectively) as 
well as particles featuring 50% of the maximal surface loading of 
either sugar (Man-ND (50%) and Glc-ND (50%)) were targeted 
for evaluation (Figure 1). In addition, mixed ND comprising 
equal proportions of both -D-mannopyranoside and -D-
glucopyranoside moieties on their surface were also fabricated 
(Glc/Man-ND) for study.  
3.1. Preparation and characterisation of ND-conjugates and 
O-glycoside monomers 
The strategy for the preparation of all sugar-conjugated ND 
studied herein involved the “click” reaction between azide-
terminated particles (ND-N3) and the appropriate propargylated 
partner(s) in the presence of CuSO4/L-ascorbic acid as catalyst, 
as previously described (Figure 1A).18 The successful integration 
of glycans onto the ND surface was confirmed by XPS and FTIR 
analysis (Supporting Information, Figure S2A, B).  
(A) 
 
(B)  
 
Figure 1. (A) Strategy for 
fabrication of glyco-ND as well as the 
structures of monomers and ND-conjugates evaluated in this work; (B) 
TEM image of Man-ND together with the corresponding size 
distribution.  
A representative transmission electron microscopy (TEM) image 
of Man-ND (Figure 1B) reveals the presence of spherical 
particles with a mean diameter of 12 ± 4 nm. The data was 
obtained from an analysis of several hundreds of NPs. The 
surface-modified layer is not visible in the TEM due to its high 
transparency to the electron beam. The calculated hydrodynamic 
diameter of glycan-modified ND is a composite value as they 
partially aggregate in solution (Table 1). The value however 
remains unchanged over days, indicating that the conjugates have 
good colloidal stability in aqueous media. For a complete set of 
TEMs at each stage of NP functionalization, see Supporting 
Information, Figure S2C. The complete characterisation data 
and physico-chemical properties, including the particle diameter 
and zeta potential of all fabricated particles are summarized in 
Table 1. The total amount of sugar conjugated to a given particle 
was quantified using the classical phenol-sulphuric acid method. 
Indeed, the role of ligand density in glycobiology is known to 
have a substantial effect on binding and ligand density on 
nanoparticles is known to change drastically the interactions 
between substrates and proteins.32-35 The analysis confirmed that 
the 50% loaded particles contained half the quantity of sugar 
present on the 100% loaded NPs (Table 1). It has to be noted that 
the phenol/sulfuric acid method does not allow discrimination 
between manno and glycopyranosides, but we make the 
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reasonable approximation that the mixed ND comprise equal 
portions of Glc/Man on the surface. The corresponding 
monovalent -O-mannoside and -O-glucoside control 
conjugates (1) and (2) (Figure 1A) required for the study were 
synthesised by the Cu(I)-catalysed “click” reaction of the 
appropriate propargyl -glycoside with 4-azidobenzoic acid 
methyl ester and proceeds smoothly.  
Tab1e. Summary of selected physico-chemical properties of ND 
particles.  
3.2. Subjection of O-glycoside―ND conjugates and 
monomers to the hydrolytic action of glycosidases 
As expected the monovalent analogs (1) and (2) are hydrolysed 
by their appropriate partner enzymes, namely -mannosidase or 
-glucosidase, respectively, but remain inert to the hydrolytic 
action of all other glycosidases tested (gas chromatography 
monitoring, see supporting information Figure S3).  
Having established the hydrolytic susceptibility of these O-
glycoside monomers free in solution, their behaviour upon being 
presented multivalently on the ND surface was examined against 
the same panel of enzymes. In order to get information on the 
recognition of glyco-ND ligands by Con A, we performed 
enzyme-linked lectin assay (ELLA) experiments. This test 
measures the ability of a soluble saccharide to inhibit the 
association between a labelled lectin (here ConA lectin labelled 
with horseradish peroxidase, ConA-HRP) and a ligand 
immobilized on the microtiter well (here a yeast mannan). The 
presence of the relatively large HRP protein label (40 kD) 
prevents two lectin moieties from approaching each other, 
resulting in 1:1 binding stoichiometries with the saccharide 
ligand. In order to discount that the ND scaffold itself might have 
a bearing on the outcome of the assay, a conjugate featuring 
hydroxymethyltriazolyl chains (devoid from any glycotope) was 
synthesized and included in the evaluation experiments as a 
negative control. Methyl -D-mannopyranoside and methyl -D-
glucopyranoside were also included as monovalent positive 
controls. 
Remarkably, both Glc-ND and Glc-ND (50%), when treated with 
the -glucosidase from baker’s yeast under classical assay 
conditions, revealed themselves to be completely stable to 
hydrolysis (the formation of mannose was not detectable by gas 
chromatography even upon incubation under assay conditions for 
24 h at 37 ºC; Figure S3) and instead behaved as competitive 
inhibitors of the enzyme, with inhibition constant (Ki) values of 
22 and 5.5 M, respectively. A hydroxyl-coated ND-conjugate 
(ND-OH), devoid from monosaccharide appendages, was 
prepared by clicking propargyl alcohol and 4-azidobenzoate-
modified ND particles (precursors C and ND-N3 in Figure 1A) 
and used as negative control. Although the low water solubility 
of ND-OH prevented an exhaustive evaluation, no significant 
glycosidase inhibition was observed at low mM concentrations, 
discarding a relevant contribution of the ND scaffold to the 
enzyme binding process. The Glc/Man-ND also displayed a 
similarly low Ki value of 1.9 M (Table 2). Screening inhibitory 
activities of Glc-ND’s against the amyloglucosidase (1,4--D-
glucan glucohydrolase) from Asp. Niger and the isomaltase 
(oligosaccharide -1,6-glucohydrolase) from baker’s yeast, both 
of which hydrolyse -glucosidic substrates, established none to 
be inhibitors of the former enzyme but all to inhibit the activity 
of the latter with Ki’s of 14.0, 4.3 and 5.5 M (for Glc-ND, Glc-
ND (50%) and Glc/Man-NDs, respectively). In a parallel series 
of experiments, Man-ND, Man-ND (50%) and Glc/Man-ND 
were screened against -mannosidase from jack bean. These 
conjugates are seen to be comparatively poor inhibitors of their 
target enzyme giving, respectively Ki’s of 517, 295 and 407M. 
Again, as expected the corresponding monomeric O-mannoside 
(1) behaves as a substrate for the jack bean -mannosidase being 
efficiently hydrolysed under standard assay conditions, whereas 
under the same conditions the corresponding O-mannoside-
conjugated ND remains intact. 
Although the origin of the inhibitory behaviour of the glyco-ND 
particles remained to be established, the finding that they do act 
as such is nonetheless unprecedented. Exposure of glycosidases 
to a fixed concentration of a glyco-ND for prolonged periods (up 
to 2 h) far in excess of the assay time saw no observable change 
in catalytic activity, discounting any possibility that protein 
denaturation by the glyco-NDs contributed to the observed 
inhibitory effects. The levels of inhibition observed for these ND-
grafted O-glycosides are better appreciated if compared with Ki 
values displayed by 1-deoxynojirimycin (DNJ), the archetypical 
natural glucosidase inhibitor.15-17 DNJ, under identical assay 
conditions to those used to screen the sugar-grafted ND particles, 
inhibits baker’s yeast -glucosidase with a Ki of 25 M, an order 
of magnitude higher than the mixed-ND (Ki 1.9M). In addition, 
the glyco-ND particles are seen indeed to exhibit some degree of 
selectivity, behaving as better inhibitors of certain enzymes than 
others, with a pattern of selectivity that does not always parallel 
that observed for DNJ (Table 1). Baker’s yeast isomaltase is 
inhibited for example by Glc-ND (50%) with a Ki of 4.3 M and 
also by DNJ (Ki of 11 M). In contrast the amyloglucosidase 
from Asp. Niger is strongly inhibited by DNJ (Ki of 2.1M), 
whereas none of the sugar-grafted particles have any inhibitory 
effect on this particular activity.  
In a bid to better understand the inhibitory activity observed for 
the various O-glycoside-conjugated ND particles, they were 
subjected to further scrutiny as inhibitors of various mismatching 
enzymes – those that do not accept either -O-glucosides or -O-
mannosides as substrates. Thus, the Glc-ND (featuring -
configured O-glucosidic units) when screened against the -
glucosidase from bovine liver, was observed to be inhibitory with 
Ki values of 113 and 44 M for the Glc-ND and the Glc-ND 
(50%), respectively and a Ki of 192 M for the Glc/Man-ND. 
The Glc-ND proved a poorer inhibitor of a second -glucosidase 
(from almond), giving Ki’s of 359, 169 and 784M for the 
corresponding 100%, 50% and mixed-sugar conjugates, 
respectively. Further, although neither the Glc-ND or Man-ND 
show activity as inhibitors of the-mannosidase from Helix 
pomatia, at the maximum concentrations tested, the Glc-ND 
(50%), Man-ND (50 %) and also the mixed-ND particles 
unexpectedly did, with Ki’s of 55, 75 and 74 M, respectively 
(Table 2). We were intrigued by the relatively relaxed inhibitory 
specificity shown by the Glc-NDs and were curious to establish 
whether this was limited solely to glycosidases acting on -D-
gluco- or -D-manno-configured substrates. The Glc-ND were 
thus tested against two additional activities: the -galactosidase 
from green coffee bean and the -galactosidase from E. 
coliBoth the Glc-ND and the Glc-ND (50%) were found to 
ND 
scaffold 
Hydrodynamic 
diameter  
(nm) 
Zeta 
potential 
(mV) 
Sugar loading 
(µg mg-1 ND) 
Sugar loading 
(glycans /ND) 
ND-OH 79 ± 13 35.3 ± 
1.6 
- - 
Man-ND 155 ± 4 26.7 ± 
0.6 
96 ± 7 (43±16) ×103 
Glc-ND 145 ± 3 24.7 ± 
0.2 
113 ± 5 (50±21) ×103 
Glc/Man-
ND 
124 ± 12 27.0 ± 
0.2 
110 ± 5 (49±20) ×103 
Man-ND 
(50 %) 
101 ± 10 28.0 ± 
0.6 
50 ± 3 (22±13) ×103 
Glc-ND 
(50 %) 
92 ± 2 28.1 ± 
0.8 
55 ± 3 (25±11) ×103 
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inhibit - and -galactosidase with almost identical potency (Ki’s 
in the range 13-33 M; Table 2). The Glc/Man-ND inhibited 
both galactoside activities but differentially, giving a Ki of 69 
 for the -galactoside and a value of 268 for the -
enzyme (Table 2).  
That O-glycoside configurational complementarity is not an 
absolute prerequisite for effective enzyme inhibition by Glc-NDs 
is particularly well borne out by their pronounced inhibition of 
mismatching glycosidases. This latter observation prompted us to 
examine the effects of the O-mannoside-grafted ND on the 
complete panel of activities at our disposal, even though these 
latter conjugates were seen to exhibit only negligible inhibition 
of the “matching” mannosidase activity. The screening reveals 
that both the Man-ND and the Man-ND (50%) inhibit the baker’s 
yeast -glucosidase activity and very significantly so, with Ki’s 
of 9.4 and 1.3 µM, respectively (Table 2). The -glucosidase 
from bovine liver is however more poorly inhibited compared to 
the -enzyme, giving Ki’s of 223 and 108 µM for the Man-ND 
and the Man-ND (50 %), respectively. In addition, the - and -
galactosidases from coffee bean and E. coli respectively are also 
strongly inhibited by the Man-ND, with Ki’s of 33 and 13 µM for 
the Man-ND and 21 and 13 µM for Man-ND (50%), respectively, 
and to an equivalent extent as that observed for the corresponding 
Glc-ND (Table 2).  
 
 
Table 2. Inhibition constants (Ki, μM) for various glyco-ND, against selected commercial glycosidases.
a 
Enzyme 
 
 
 
Glc-ND 
 
Glc-ND (50%) 
 
      Glc/Man-ND 
 
 
         Man-ND 
 
   Man-ND (50%) 
-glucosidase 
(baker’s yeast) 
22 ± 2 5.5 ± 0.2 1.9 ± 0.1 9.4 ± 0.3 1.3 ± 0.1 
Amyloglucosida
se 
(Asp. niger) 
NIb NI NI NI NI 
Isomaltase 
(baker’s  yeast) 
14 ± 0.5 4.3 ± 0.2 5.5 ± 0.2 12.0 ± 0.5 2.6 ± 0.2 
-mannosidase 
(jack bean) 
419 ± 35 222 ± 15 407 ± 30 517 ± 50 295 ± 20 
-glucosidase 
(bovine liver) 
113 ± 5 44 ± 2 192 ± 5 223 ± 10 108 ± 5 
-glucosidase 
(almonds) 
359 ± 20 169 ± 10 784 ± 50 323 ± 15 105 ± 5 
-mannosidase 
(Helix pomatia) 
NI 55 ± 3 74 ± 5 NI 75 ± 4 
-galactosidase 
(coffee beans) 
31 ± 2 22 ± 2 69 ± 5 33 ± 2 21 ± 2 
-galactosidase 
(E. coli) 
22 ± 1 17± 1 268 ± 25 13 ± 2 13 ± 1 
a Inhibition was reversible and competitive in all cases except for Glc-ND (50%) against yeast -glucosidase (yeast maltase), for which a mixed-mode 
inhibition mode was observed. b NI: no inhibition observed at 1 mM. 
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Figure 2. ELLA plots (logarithm scale) for the inhibition of ConA-HRP 
binding to yeast mannan with increasing concentrations of the various 
glyco-ND on a sugar content basis. The corresponding IC50 values are 
expressed as mean ± SD (n = 3). 
It is worthwhile noting that, while the Ki values recorded for 
glycoside-coated ND do not vary dramatically from one another 
with sugar loading (100% vs 50%) for the majority of enzymes 
tested, this trend is seen not to be true for the -mannosidase 
from Helix pomatia: for the latter enzyme, the 50% Glc- and 50% 
Man-NDs as well as the mixed ND are inhibitory, whereas the 
100% Glc- and Man-NDs are not. 
The inhibition data suggests that the mode-of-recognition of the 
O-glycoside-grafted particles by a particular glycosidase is quite 
different from that usually harnessed by that enzyme for 
monovalent substrate hydrolysis. Non-specific aggregation of the 
glyco-NDs with the tested glycosidases seems improbable 
considering the observed inhibition activity profiles. Indeed, 
monosaccarides are currently used as passivation molecules to 
avoid unspecific interactions of nanoparticles with biomolecules 
in physiological media.36, 37 The impact on factors such as 
glycotope density and heteromultivalency in glycosidase 
inhibition is more reminiscent of that encountered in 
carbohydrate-lectin recognition events.37 We were in a position 
to establish whether or not this was indeed the case and set about 
evaluating the performance of the various glyco-ND as ligands 
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for lectins such as concanavalin A (ConA), a tetravalent protein 
known to recognize both -D-mannopyranosides and -D-
glucopyranosides. The abilities of the glyco-ND to bind, cross-
link and aggregate ConA as assessed by a range of methods 
including an enzyme-linked lectin assay (ELLA; Figure 2), a 
two-site sandwich ELLA and a turbidimetry assay, respectively 
(see supporting information Figure S4 and Figure S5),36 were 
duly investigated and indeed seen to reflect their expected per 
glycotope affinity enhancements as compared to monovalent 
controls: the high avidity of the lectin for each respective 
glycosylated ND particles is consistent with the manifestation of 
potent multivalent effects driving lectin recognition and binding.  
Sandwich-type competitive glycosidase-lectin ELLA 
Having established that Glc- and Man-ND behave not only as 
inhibitors of various glycosidases, but also as ligands of ConA, a 
newly developed sandwich-type competitive glycosidase-lectin 
ELLA was implemented in the hope of garnering further insights 
into the mechanism(s) of enzyme inhibition by the glyco-ND. 
The experimental setting is an interface composed of a mannan 
polysaccharide adsorbed on a polystyrene microtiter well, onto 
which is applied a second layer constituted of the tetrameric, and 
therefore cross-linkable, lectin ConA (Figure 3A). 
We reasoned that, if a glycosidase capable of competing with 
horseradish peroxidase (HRP)-labelled ConA (HRP-ConA) for 
binding a given glyco-ND were to be included in the mix, a 
concentration-dependent decrease in lectin cross-linking would 
ensue. Moreover, inclusion of an excess of a potent active site-
directed inhibitor of the particular glycosidase being tested, 
would result in an assay that reported indirectly, on the extent to 
which the active site is implicated in any glyco-ND―enzyme 
complex. We reasoned too that were the assay to be performed 
with an inhibitor capable of spanning both the catalytic and 
aglycone binding sites simultaneously, it would then afford 
insights into the impact of glyco-ND—aglycone binding on 
inhibition. (Figure 3A).34 We hoped that the data taken together, 
would allow the relative individual contributions of either the 
active site or any peripheral binding region on a particular 
enzyme, in glyco-ND recognition to be ascertained and thus 
provide insights into the possible mode(s)-of-inhibition in play.  
 
 
Figure 3. A) Schematic representation of the ConA—yeast -glucosidase 
(maltase) competitive ELLA; the structures of the active site-directed 
glycone-type inhibitor (3) and the pseudodisaccharide derivative (4), used 
as controls to map the implication of, respectively, the glycone and, the 
aglycone site in glyco-ND binding to the enzyme are depicted. B) Plots of 
the relative ConA cross-linking capability of Man-ND as a function of 
maltase concentration in the absence or in the presence of an excess of (3) 
or (4), respectively (Figure S6). 
The ConA―Glc-ND―HRP-ConA cross-linking inhibition plots 
for yeast -glucosidase (yeast maltase) alone or in the presence 
of the competitive maltase inhibitors nojirimycin 5N,6O-(cyclic 
carbamate) (3) (Ki = 2.2 M)
34, 38 and methyl 6-O-[nojirimycin-
1-yl 5N,6O-(cyclic carbamate)]--D-glycopyranoside (4) (Ki = 
5.5 M)39 are each depicted in Figure 3B. Both (3) and (4) are 
active-site directed inhibitors: compound (3), a monosaccharide 
mimic, binds exclusively at the glycone (-1) site of the enzyme 
whereas the isomaltose mimic (4) spans simultaneously both the 
glycone (-1) and the aglycone (+1) sites. In the presence of the 
monosaccharide-like inhibitor (3), and thus when the glycone site 
of maltase is occupied, the data indicates that the ability of the 
enzyme to compete with the lectin for the Glc-ND is only 
nominally compromised. In contrast, any ability of the glyco-ND 
to form an ND-maltase complex is seen to be severely perturbed 
in the presence of the pseudodisaccharide homologue (4) and, 
consequently, lectin cross-linking is largely unimpeded. Identical 
trends were recorded for the 50% Glc-, 100% and 50% Man-, 
and mixed Glc/Man-ND conjugates in this assay (see Figure S6).  
Although the remarkable difference between monovalent and 
multivalent O-glycosides towards the hydrolytic action of 
glycosidases revealed herein would appear difficult to reconcile 
with the typical modes-of-action currently accepted for 
glycosidases, the evidence of the sandwich type competitive 
enzyme-lectin ELLA allows a plausible alternative mode-of-
inhibition to be put forward for the glyco-ND: one that does not 
parallel the mode of substrate recognition typical of enzymatic 
hydrolysis, but that instead implicates the interaction of O-
glycoside moieties present in glyco-ND with the aglycone 
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binding sites of the target enzymes as one of the primary driving 
forces underpinning their inhibitory activity. This hypothesis is 
consistent with the fact that the interaction of a given substrate 
with the catalytic cleft of a particular enzyme is dependent on the 
interactions of both its glycone and aglycone constituents. 
Aglycone-binding sites of glycosidases are known to accept a 
range of structural motifs, and substrates featuring certain of 
these motifs have been shown be much more susceptible to 
enzymatic hydrolysis. Indeed, the exploitation of such aglycone 
site-interactions in glycosidase inhibitor design was recognized 
some twenty years ago.40 Glycosidase inhibitors targeting 
exclusively the aglycone binding site of glucosidases have been 
reported but are rare.41 On the other hand, hybrid compounds in 
which a judiciously selected aglycone moiety and a glycomimetic 
inhibitor are combined, have been reported to display improved 
inhibitory potencies and selectivities for their target enzymes 
compared with compounds featuring only one of the constituent 
fragments.42 
As far as we are aware, prior to the present work there has been 
no report of the transformation of an O-glycoside substrate of a 
glycosidase into an inhibitor, simply upon being presented 
multivalently on a scaffold. The resistance of a number of O-
glycoside-supported gold NPs to the hydrolytic action of various 
glycosyl hydrolases has on the other hand been examined 
previously, although these glyco-NPs were not reported to be 
inhibitors of these enzymes.35, 43-45 Indeed we are only aware of a 
single previous study that explored multivalent O-glycosides as 
glycosidase inhibitors.  In that, the large bacterial sialidase from 
V. cholerae, that features a catalytic module flanked by two lectin 
domains (carbohydrate binding modules or CBMs) was reported 
to be strongly inhibited by a synthetic polymer featuring multiple 
O-galactosyl units.46 The latter glycopolymer was proposed to 
owe its activity to its interaction with the CBMs of the V. 
cholerae sialidase, effectively leading to their “sequestration”, 
resulting in seriously compromising its ability to hydrolyse 
multivalent O-sialoside substrates. The role of CBMs in catalysis 
has now been widely examined 47-49 but as far as we are aware, 
catalysis by the enzymes explored in the present study does not 
benefit from the presence of discrete flanking CBMs. However, 
binding of multivalent glyco-ND to distal non-catalytic domains 
other than CBMs of glycosidases would be expected also to lead 
to a reduction in their catalytic efficiency.50-52 No such domains 
have been established for any of the enzymes studied here. 
Additionally, although the -galactosidase from E. colifeatures 
multiple catalytic domains53 and is thus expected to be 
susceptible to inhibition by appropriate multivalent constructs, it 
is nevertheless inhibited by both Glc-ND and the Glc-ND (50%) 
to the same extent and, moreover, only to the same level as seen 
for the -galactosidase from coffee bean which only features a 
single such domain. 
 
4. Conclusions 
We describe in this study the unprecedented finding that -D-O-
glucosides as well as -D-O-mannosides when grafted 
multivalently on the surface of ND particles are not only 
rendered stable towards the hydrolytic action of the 
corresponding matching glycosidases, but are also endowed with 
the ability to inhibit these enzymes. Moreover, conjugation of the 
O-glycosides to ND sees them behaving as inhibitors of enzymes 
for which they do not serve as substrates even when in their 
monovalent, free form. Furthermore, the inhibitory potency of a 
particular glyco-ND edifice towards a given enzymatic activity is 
demonstrated to be dependent not only on the particular sugar 
motif grafted (-D-gluco or -D-manno) but also on whether the 
glycosidic moieties are presented in homogeneous displays, or as 
a mixture of glycotopes on a single particle and additionally 
varies with their surface density (100 or 50% loading). The data 
support that inhibition by the glyco-ND cannot be one that is 
catalytic site-independent as has previously been put forward to 
rationalize the mode-of-inhibition of iminosugar constructs.34 
Instead, the data of the ConA—yeast -glucosidase competitive 
ELLA support an alternative mode-of-inhibition in which glyco-
ND are able to competitively inhibit catalytic activity through 
formation of the corresponding glyco-ND―enzyme complexes 
by harnessing of interactions with the enzyme aglycone binding 
sites. That additional modes-of-binding might also be operational 
for one or more enzymes in the panel tested here, cannot be 
discounted at this stage and remain to be fully elaborated. 
However, the distinct preferences for sugar motif recognition, 
dependence on multivalency, heteromultivalency and 
architectural parameters of a particular glyco-ND, do parallel 
closely those previously observed for interactions of multivalent 
ligands with lectins. The mode-of-inhibition implicating 
aglycone binding proposed here would support that the modes of 
interaction of glyco-ND with enzymes and lectins share much in 
common and begs the question as to whether or not this might 
also hold true for alternate multivalent carbohydrate analogs. 
To the best of our knowledge other O-glycoside-based 
multivalent constructs – many known to interact potently with 
lectins – have not yet been evaluated as putative inhibitors of 
glycosidases, although multivalent iminosugar analogs have been 
extensively studied in recent years.54, 55 It is reasonable to expect 
that the novel phenomenon uncovered here may not be limited 
solely to NDs but is likely also to be manifested by multivalent 
constructs derived using other nanoparticles or alternate 
scaffolds. The present data are limited to -O-glucosides and -
O-mannosides. The incertitude on the mechanistic aspects makes 
it inappropriate to speculate about the possibility of other O-
glycosides also promoting glycosidase inhibition when presented 
on appropriate scaffolds.  
The findings reported herein promise to impact on our 
understanding of the mechanisms-of-action of glycosyl 
hydrolases (and possibly those of other catalytic proteins) and 
will undoubtedly provide new opportunities for the design of 
synthetic enzyme inhibitors. The possibility that a multivalent 
ligand designed to modulate a selected lectin-ligand interaction 
might show cross-reactivity with one or more glycosidase, would 
seem to further complicate the development of multivalent 
compounds as therapeutic agents. Moreover, should any native 
multivalent glycodisplay be shown to inhibit, and thereby 
modulate, glycosidase action in vivo, this would need to be taken 
into account when rationalising a wide range of key biological 
phenomena known to be sensitive to the presence of glycans.56-58  
 
Acknowledgements 
A.B, R.B and S.S. gratefully acknowledge financial support from 
the Centre National de la Recherche Scientifique (CNRS), the 
Université Lille 1, the Nord Pas de Calais region and the Institut 
Universitaire de France (IUF). A.S. and O.B. acknowledge 
financial support from the CNRS and the IFCPAR for a 
postdoctoral fellowship to O.B. (Project 3905-1). C.O.M. and 
J.M.G.F. are grateful to the Spanish Ministerio de Economía y 
Competitividad (contract numbers SAF2013-44021-R and 
CTQ2010-15848), the Junta de Andalucía (contract number 
FQM2012-1467 and postdoctoral fellowship to T.M.-B.) and the 
European Regional Development Funds (FEDER and FSE) for 
financial support and the CITIUS (University of Seville) for 
technical assistance. We also acknowledge support from the 
European Union through the FP7-PEOPLE-2010-IRSES action 
“Photorelease” (grant number 269099) and the COST action 
CM1102 “MultiGlycoNano”. 
ARTICLE RSC Advances 
10 | RSC Adv., 2015, 00, 1-3  
 
Notes  
a Laboratoire de Glycochimie des Antimicrobiennes et Bioreseources, 
FRE 3517, Université de Picardie Jules Verne, 80039 Amiens, 
 France; e-mail: aloysius.siriwardena@u-picardie.fr  
b Institute of Electronics, Microelectronics and Nanotechnology (IEMN), 
UMR-CNRS 8520, Lille1 University, Avenue Poincaré-BP 60069, 59652 
Villeneuve d’Ascq,  France; e-mail: sabine.szunerits@iri.univ-lille1.fr 
c Faculty of Chemistry, University of Sevilla, C/ Profesor Garcia 
Gonzalez 1, E-41012 Sevilla, Spain; e-mail: mellet@us.es  
d Instituto de Investigaciones Químicas (IIQ), CSIC – Universidad de 
Sevilla, Avda. Américo Vespucio 49, E-41092 Sevilla, Spain; e-mail: 
jogarcia@iiq.csic.es 
 
 
 
References 
1  H. Hevey, L. Chang-Chun, Adv. Carbohydr. Chem. Biochem. , 2013, 
125, 125. 
2  T.R. Branson, T.E. McAllister, J. Garcia-Hartjes, M.A. Fasciones, 
J.F. Ross, S.L. Warriner, T. Wennekes, H. Zuilhof, W.B. Turnbull, 
Angew. Chem. Int. Ed., 2014, 53, 8323. 
3  T.K. Dam, T. A. Gerken, C. F. Brewer, Biochem., 2009, 48, 3822. 
4  E. Fan, Z. Zhang, W.E. Minke, Z. Hou, C.L.M. J. Verlinde, W.G.J. 
Hol, J. Am. Chem. Soc., 2000, 122, 2663. 
5  C. Fasting, C. A. Schalley, M. Weber, O. Seitz, S. Hecht, B. Koksch, 
J. Dernedde, C. Graf, E.-W.Knapp, R. Haag, Angew. Chem. Int. Ed., 
2012, 5, 10472. 
6  P.I. Kitov, J.M. Sadowska, G. Mulvey, G.D. Armstrong, H. Ling, 
N.S. Pannu, R.J. Read, D.R. Bundle, Nature, 2000, 403, 669. 
7  J.J. Lundquist, E.J. Toone, Chem. Rev., 2002, 102, 555. 
8  K.-F. Mo , T. Fang , S. H. Stalnaker , P. S. Kirby , M. Liu , L. Wells , 
M. Pierce , D. H. Live , G.-J. Boons, J. Am. Chem. Soc., 2011, 133, 
14418. 
9  G.T. Nobel, F.L. Craven , J. Voglmeir , R. Šardzík , S.L. Flitsch, S.J. 
Webb J. Am. Chem. Soc., 2012, 134, 13010. 
10 C.M. Payne, W. Jiang, M. R. Shirts, M. E. Himmel, M. F. Crowley, 
G. T. Beckham, J. Am. Chem. Soc. , 2013, 135, 18831. 
11  Z. Wang, Z. S. Chinoy, S. G. Ambre, W. Peng, R. McBride, R. P. de 
Vries, J. Glushka, J. C. Paulson, G. J. Boons, Science, 2013, 341, 
379. 
12  V. Wittmann, R.J. Pieters, Chem. Soc. Rev. , 2013, 42, 4492. 
13  B.T. Houseman, M. Mrksich, Angew Chem Int Ed, 1999, 38, 782. 
14  A. Bernardi, J. Jiménez-Barbero, A. Casnati, C. De Castro, T. 
Darbre, F. Fieschi, J. Finne, H. Funken, K.-E. Jaeger, M. Lahmann, 
T.K. Lindhorst, M. Marradi, P. Messner, A. Molinaro, P.V. Murphy, 
C. Nativi, S. Oscarson, S. Penads, F. Peri, R.J. Pieters, O. Renaudet, 
J.-L. Reymond, B. Richichi, J. Rojo, F. Sansone, C. Schäffer, W.B. 
Turnbull, T. Velasco-Torrijos, S. Vidal, S. Vincent, T. Wennekes, H. 
Zuilhof, A. Imberty, Chem. Soc. Rev., 2013, 42, 4709. 
15  T.M. Gloster, D.J. Vocadlo, Nat. Chem. Biol., 2012, 8, 683-669. 
16  R.J. Nash, A. Kato, C.Y. Yu, G.W.J. Fleet, Future Med. Chem, 2011, 
3, 1513-1521. 
17 A.E. Stütz, T.M. Wrodnigg, Adv. Carbohydr. Chem. Biochem., 2011, 
66, 187-298. 
18  A. Barras, F.A. Martin, O. Bande, J.S. Baumann, J.-M. Ghigo, R. 
Boukherroub, C. Beloin, A. Siriwardena, S. Szunerits, Nanoscale, 
2013, 5, 2307. 
19  M. Khanal, F. Larsonneur, V. Raks, A. Barras, J.-S. Baumann, F. 
Ariel Martin, R. Boukherroub, J.-M. Ghigo, C. Ortiz Mettet, V. 
Zaitsev, J.M. Garcia Fernances, C. Beloin, A. Siriwardena, S. 
Szunerits Nanoscale, 2015, 7, 2325. 
20  M. Khanal, T. Vausselin, A. Barras, O. Bande, K. Turcheniuk, M. 
Benazza, V. Zaitsev, C.M. Teodurescu, R. Boukherroub, A. 
Siriwardena, J. Dubuisson, S. Szunerits, ACS Appl. Mater. 
Interfaces, 2013, 5, 12488. 
21  R. Martin, M. Alvaro, J.R. Herance, H. Garcia, ACS Nano, 20110, 4, 
65. 
22  I. Rehor, Slegerova, J. J.Kucka, V. Proks, V. Petrakova, M.-P. Adam, 
F. Treussart, S. Turner, S. Bals, P. Sacha, M. Ledvina, A.M. Wen, 
N.F. Steinmetz, P. Cigler, Small, 2014, 10, 1106. 
23  J. Slegerova, M. Hajek, I. Rehor, F. Sedlak, J. Stursa, M. Hruby, P. 
Cigler, Nanoscale, 2015, 7, 415. 
24  J. Wehling, R. Dringer, R.N. Zare, M. Maas, K. Rezwan, ACS Nano, 
2014, 8, 6475. 
25  V. Turcheniuk, V. Raks, R. Issa, I.R. Cooper, P.J. Cragg, R. Jijie, N. 
Dumitrescu, L.I. Mikhalovska, A. Battas, V. Zaitsev, R. 
Boukherroub, S. Szunerits, Diam. Rel.Mater., 2015, 
http://dx.doi.org/10.1016/j.diamond.2014.12.002. 
26  L. Marcon, F. Riquet, D. Vicogne, S. Szunerits, J.-F. Bodart, R. 
Boukherroub, J. Mater. Chem. , 2010, 20, 8064. 
27  A.M. Schrand, H. Huang, C. Carlson, J.J. Schlager, E. Osawa, S.M. 
Hussain, L. Dai, J. Phys. Chem. B, 2007, 111, 2. 
28  S.-J. Yu, M.-W. Kang, H.-C. Chang, K.-M. Chen, Y.-C. Yu, J. Am. 
Chem. Soc., 2005, 127, 17604. 
29  M. Khanal, V. Raks, R. Issa, V. Chernyshenko, A. Barras, J.M. 
Garcia Fernandes, A. Siriwardena, I. Cooper, P. Cragg, L.I. 
Mikhalovska, V. Zaitsev, R. Boukherroub, S. Szunerits, Part. Part. 
Syst. Charact., 2015,  DOI: 10.1002/ppsc.201500027. 
30  M. Hartmann, P. Betz, Y. Sun, S.H. Gorb, T.K. Lindhorst, A. 
Krueger, Chem. Eur. J.,, 2012, 18, 6485. 
31  B. Arribas , E. Suárez-Pereira , C. Ortiz Mellet, J.M. García 
Fernández, C. Buttersack , M.E. Elena Rodríguez-Cabezas , N. 
Garrido-Mesa , E. Bailon, E. Guerra-Hernández, A. Zarzuelo, J. 
Gálvez J. Agric. Food Chem. , 2010, 58, 1777. 
32  D.A. Giljohann, D.S. Seferos , P.C. Patel , J.E. Millstone, N.L. Rosi, 
C.A. Mirkin, Nano Lett., 2007, 7, 3818. 
33  I. Papp, C. Sieben, K. Ludwig, M. Roskamp, C. Bottcher, S. 
Schlecht, A. Hermann, R. Haag, Small, 2010, 6, 2099. 
34  R. Rísquez-Cuadro, J.M. García Fernández, J.-F. Nierengarten, C. 
Ortiz Mellet, Chem. Eur. J., 2013, 19, 16791. 
35  A.G. Barrientos, J.M. de la Fuente, M. Jiménes, D.C. Solis, F. J. , M. 
Martin-Lomas, S. Penades, Carbohydr. Res., 2009, 344, 1474. 
36  M. Moros, B. Hernáez, E. Garet, J.T. Dias, B. Sáez, V. Grazú, A. 
González-Fernández, C. Alonso, J.M. de la Fuente, ACS Nano, 2012, 
6, 1565. 
37  M. Moros, B. Pelaz, P. López-Larrubia, M.L. García-Martin, V. 
Grazú, J.M. de la Fuente, Nanoscale, 2010, 2, 1746. 
38  V.M. Díaz Pérez, M.I. García-Moreno, C. Ortiz Mellet, J. Fuentes, 
J.C. Díaz Arribas, C.F. J., J.M. García Fernández, J. Org. Chem. , 
2000, 65, 136. 
39  E.M. Sánchez-Fernández, R. Rísquez-Cuadro, C. Ortiz Mellet, J.M. 
García Fernández, P.M. Nieto, J. Angulo, Chem. Eur. J., 2012, 18, 
8527. 
40  R.A. Field, A.H. Haines, Bioorg. Med.Chem Lett., 1991, 1, 661. 
41  H. Bharathkumar, M.S. Sundaram, S. Jagadish, S. Paricharak, M. 
Hemshekhar, D. Mason, K. Kemparaju, K.S. Girish, Basappa, A. 
Bender, K.S. Rangappa, PLOS ONE, 2014, 9, e102759. 
42  J. Castilla, R. Rísquez, D. Cruz, K. Higaki, E. Namba, K. Ohno, Y. 
Suziki, Y. Díaz, C. Ortiz Mellet, J.M. García Fernández, S. Castillón, 
J. Med. Chem., 2012, 55, 6857. 
43  J.M. de la Fuente, A.G. Barrientos, T.C. Rojas, J. Rojo, J. Canada, A. 
Fernandez , S. Penades, Angew Chem Int Ed, 2001, 40, 2257. 
44  N.C. Reichardt, M. Martin-Lomas, S. Penades, Chem. Soc. Rev., 
2013, 42, 4358. 
45  M.B.S. Thygesen, J., K.J. Jensen, Chem. Eur. J., 2009, 15, 1649. 
46  S. Thobhani, B. Ember, A. Siriwardena, G.-J. Boons, J. Am. Chem. 
Soc., 2003, 125, 7154. 
47  A.B. Boraston, D.N. Bolam, H.J. Gilbert, G.J. Davies, Biochem. J., 
2004, 382, 769. 
48  H.J. Gilbert, Plant. Physiol., 2010, 153, 444. 
49  D. Guillén, S. Sánchez, R. Rodríguez-Sanoja, App. Microbiol. 
Biotechnol., 2010, 85, 1241. 
50 S. Cuyvers, E. Dornez, J.A. Delcour, C.M. Courtin, Critical Reviews 
in Biotechnology, 2012, 32, 93. 
51 E.C. O’Neill, A. Rashid, C.E.M. Stevenson, A.-C. Hetru, A.P. 
Gunning, M. Rejzek, S. A. Nepogodiev, S. Bornemann, D. M. 
Lawson, R. A. Field, Chem. Sci., 2014, 4, 341. 
52  C. Ragunath, S.G. Manuel, V. Venkataraman, H.B. Sait, C. 
Kasinathan, N. Ramasubbu, J. Mol. Biol., 2008, 384, 1232. 
53  R.H. Jacobson, X.-J. Zhang, R.F. DuBose, B.W. Matthews, Nature 
1994, 369, 761. 
54  P. Compain, A. Bodlenner, 2014, 15, 1239. 
55  S.G. Gouin, Chem. Eur. J., 2014, 20, 11616. 
56  J.W. Dennis, C.F. Brewer, Mol Cell Proteomics, 2013, 12, 913. 
57  A. Varki, R. D.Cummings, J. D. Esko, H. H. Freeze, P. Stanley, C. 
R. Bertozz, G. W. Hart, M. E. Etzler, Essentials of Glycobiolog, 
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 
2009. 
58  B. Wang, B. G-J, Carbohydrate Recognition: Biological Problems, 
Methods, and Applications., John Wiley & Sons, Hoboken, 2011. 
 
ARTICLE 
 RSC Adv., 2015, 00, 1-3 | 11  
 
